N
NeoPharm Co Ltd
KOSDAQ:092730
NeoPharm Co Ltd
KOSDAQ:092730
Price:
19 850
KRW
-1.73%
Market Closed
Market Cap:
₩318.2B
Balance Sheet
Balance Sheet Decomposition
NeoPharm Co Ltd
NeoPharm Co Ltd
Balance Sheet Decomposition is not available for
NeoPharm Co Ltd
NeoPharm Co Ltd
Balance Sheet
NeoPharm Co Ltd
NeoPharm Co Ltd
Currency: KRW
| Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||
| Cash & Cash Equivalents |
591
|
1 921
|
1 656
|
1 119
|
2 658
|
1 682
|
1 799
|
6 662
|
8 004
|
7 613
|
4 244
|
8 421
|
5 515
|
11 188
|
7 049
|
10 883
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
860
|
325
|
520
|
731
|
772
|
989
|
1 584
|
1 419
|
1 986
|
0
|
0
|
|
| Cash Equivalents |
591
|
1 921
|
1 656
|
1 119
|
2 658
|
822
|
1 474
|
6 142
|
7 273
|
6 841
|
3 255
|
6 837
|
4 096
|
9 202
|
7 049
|
10 883
|
|
| Short-Term Investments |
6 500
|
4 003
|
3 833
|
5 475
|
5 589
|
7 600
|
8 665
|
7 647
|
5 118
|
16 616
|
27 184
|
34 000
|
80 000
|
84 992
|
98 000
|
102 602
|
|
| Total Receivables |
3 292
|
2 479
|
3 191
|
3 778
|
3 950
|
3 960
|
4 440
|
3 591
|
4 700
|
4 611
|
7 426
|
9 184
|
9 626
|
8 863
|
8 045
|
7 665
|
|
| Accounts Receivables |
3 160
|
2 426
|
2 914
|
3 036
|
3 504
|
3 496
|
3 990
|
3 561
|
4 660
|
4 463
|
7 339
|
9 099
|
9 473
|
8 739
|
7 967
|
7 596
|
|
| Other Receivables |
132
|
53
|
277
|
742
|
446
|
464
|
450
|
30
|
40
|
148
|
87
|
85
|
153
|
124
|
78
|
69
|
|
| Inventory |
566
|
767
|
1 138
|
1 151
|
1 507
|
2 125
|
2 605
|
2 847
|
4 245
|
4 157
|
4 844
|
6 844
|
5 840
|
8 090
|
7 973
|
8 749
|
|
| Other Current Assets |
289
|
555
|
820
|
861
|
390
|
609
|
431
|
893
|
984
|
711
|
350
|
488
|
699
|
418
|
416
|
1 371
|
|
| Total Current Assets |
11 237
|
9 724
|
10 638
|
12 383
|
14 094
|
15 976
|
17 940
|
21 640
|
23 052
|
33 707
|
44 047
|
58 937
|
101 680
|
113 551
|
121 484
|
131 270
|
|
| PP&E Net |
6 786
|
8 642
|
10 014
|
10 190
|
10 145
|
9 530
|
8 957
|
8 416
|
8 259
|
8 635
|
8 918
|
10 441
|
10 496
|
10 121
|
9 743
|
9 341
|
|
| PP&E Gross |
6 786
|
8 642
|
10 014
|
10 190
|
10 145
|
9 530
|
8 957
|
8 416
|
8 259
|
8 635
|
8 918
|
10 441
|
10 496
|
10 121
|
9 743
|
9 341
|
|
| Accumulated Depreciation |
584
|
923
|
1 573
|
2 389
|
3 232
|
3 968
|
4 440
|
5 017
|
5 655
|
5 935
|
6 134
|
6 326
|
6 985
|
7 500
|
7 940
|
8 129
|
|
| Intangible Assets |
1 215
|
1 135
|
1 744
|
1 351
|
1 272
|
1 167
|
1 358
|
1 255
|
1 098
|
1 229
|
1 203
|
1 171
|
2 384
|
2 380
|
2 055
|
1 786
|
|
| Goodwill |
0
|
0
|
5 903
|
5 298
|
4 629
|
3 934
|
2 785
|
1 519
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
335
|
379
|
186
|
811
|
367
|
19
|
0
|
0
|
56
|
78
|
69
|
80
|
89
|
115
|
117
|
118
|
|
| Long-Term Investments |
1 254
|
2 667
|
2 807
|
1 644
|
1 797
|
1 789
|
1 945
|
2 357
|
6 962
|
2 716
|
1 863
|
1 656
|
7 035
|
5 992
|
9 192
|
12 059
|
|
| Other Long-Term Assets |
793
|
1 088
|
1 032
|
1 361
|
1 697
|
1 728
|
1 774
|
649
|
983
|
143
|
595
|
643
|
1 058
|
818
|
818
|
773
|
|
| Other Assets |
0
|
0
|
5 903
|
5 298
|
4 629
|
3 934
|
2 785
|
1 519
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
21 621
N/A
|
23 636
+9%
|
32 326
+37%
|
33 038
+2%
|
34 001
+3%
|
34 142
+0%
|
34 759
+2%
|
35 836
+3%
|
40 409
+13%
|
46 509
+15%
|
56 695
+22%
|
72 928
+29%
|
122 742
+68%
|
132 978
+8%
|
143 408
+8%
|
155 347
+8%
|
|
| Liabilities | |||||||||||||||||
| Accounts Payable |
410
|
292
|
683
|
455
|
638
|
700
|
789
|
1 030
|
2 065
|
2 263
|
2 760
|
3 462
|
3 174
|
4 194
|
4 347
|
3 703
|
|
| Accrued Liabilities |
514
|
191
|
279
|
204
|
154
|
241
|
320
|
347
|
248
|
377
|
636
|
759
|
862
|
737
|
766
|
885
|
|
| Short-Term Debt |
0
|
0
|
700
|
700
|
0
|
116
|
0
|
0
|
0
|
0
|
0
|
0
|
400
|
4 000
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
257
|
384
|
145
|
536
|
260
|
432
|
24
|
400
|
40
|
57
|
64
|
0
|
256
|
290
|
457
|
412
|
|
| Other Current Liabilities |
1 075
|
1 285
|
1 123
|
1 088
|
2 064
|
1 821
|
1 616
|
1 972
|
5 027
|
5 059
|
5 555
|
8 673
|
8 139
|
5 655
|
7 371
|
8 136
|
|
| Total Current Liabilities |
2 256
|
2 152
|
2 930
|
2 983
|
3 116
|
3 309
|
2 749
|
3 749
|
7 380
|
7 756
|
9 015
|
12 894
|
12 831
|
14 877
|
12 941
|
13 137
|
|
| Long-Term Debt |
484
|
377
|
569
|
161
|
354
|
0
|
900
|
0
|
0
|
0
|
0
|
400
|
4 000
|
19
|
102
|
0
|
|
| Other Liabilities |
237
|
504
|
416
|
440
|
659
|
909
|
774
|
942
|
406
|
182
|
98
|
347
|
218
|
364
|
61
|
0
|
|
| Total Liabilities |
2 978
N/A
|
3 033
+2%
|
3 915
+29%
|
3 585
-8%
|
4 129
+15%
|
4 218
+2%
|
4 423
+5%
|
4 691
+6%
|
7 786
+66%
|
7 938
+2%
|
9 113
+15%
|
13 641
+50%
|
17 049
+25%
|
15 260
-10%
|
13 103
-14%
|
13 137
+0%
|
|
| Equity | |||||||||||||||||
| Common Stock |
2 578
|
3 326
|
3 731
|
3 731
|
3 731
|
3 731
|
3 731
|
3 731
|
3 731
|
3 731
|
3 731
|
3 731
|
4 104
|
4 104
|
4 104
|
4 104
|
|
| Retained Earnings |
8 378
|
11 409
|
12 653
|
13 335
|
13 806
|
13 813
|
15 315
|
17 125
|
18 558
|
24 450
|
33 279
|
44 757
|
59 085
|
71 100
|
83 848
|
96 106
|
|
| Additional Paid In Capital |
8 752
|
8 068
|
13 536
|
13 566
|
13 536
|
13 543
|
13 536
|
13 536
|
13 536
|
13 536
|
13 536
|
13 536
|
45 133
|
45 133
|
45 684
|
45 684
|
|
| Unrealized Security Profit/Loss |
0
|
56
|
49
|
4
|
17
|
20
|
0
|
0
|
0
|
18
|
30
|
81
|
73
|
66
|
33
|
485
|
|
| Treasury Stock |
1 065
|
2 144
|
1 343
|
669
|
669
|
669
|
0
|
2 679
|
2 679
|
2 679
|
2 679
|
2 679
|
2 679
|
2 679
|
2 679
|
2 679
|
|
| Other Equity |
0
|
0
|
215
|
514
|
514
|
514
|
2 245
|
566
|
521
|
484
|
314
|
138
|
23
|
6
|
619
|
519
|
|
| Total Equity |
18 643
N/A
|
20 603
+11%
|
28 411
+38%
|
29 453
+4%
|
29 872
+1%
|
29 924
+0%
|
30 336
+1%
|
31 146
+3%
|
32 624
+5%
|
38 571
+18%
|
47 582
+23%
|
59 287
+25%
|
105 693
+78%
|
117 718
+11%
|
130 305
+11%
|
142 211
+9%
|
|
| Total Liabilities & Equity |
21 621
N/A
|
23 636
+9%
|
32 326
+37%
|
33 038
+2%
|
34 001
+3%
|
34 142
+0%
|
34 759
+2%
|
35 836
+3%
|
40 409
+13%
|
46 509
+15%
|
56 695
+22%
|
72 928
+29%
|
122 742
+68%
|
132 978
+8%
|
143 408
+8%
|
155 347
+8%
|
|
| Shares Outstanding | |||||||||||||||||
| Common Shares Outstanding |
7
|
6
|
7
|
7
|
7
|
7
|
7
|
7
|
7
|
7
|
7
|
7
|
8
|
8
|
16
|
8
|
|
Switch to:
Switch to:
See Also
Discover More
